Skip to main content

Dr. Mark Roschewski is a clinician scientist currently serving as the Clinical Director of the Lymphoid Malignancies Branch of the Center for Cancer Research, National Cancer Institute in Bethesda, Maryland. There, the primary goal of his research team is to translate novel findings from the molecular biology of lymphoma into innovative therapies for lymphomas. In addition to his team’s work demonstrating the effectiveness of new targeted therapies, his team collaborates on developing circulating tumor DNA (ctDNA) as a predictive and prognostic biomarker in diffuse large B-cell lymphoma and other lymphoma subtypes.

Leave a Reply